PER 1.23% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-23

  1. 35,754 Posts.
    lightbulb Created with Sketch. 554
    Not really far of zeus, really you're giving heaps of credit with 2c

    Take out that fruity 10/1 consolidation it's at o.36 of a cent but since you don't use that many points past the decimal we'll round up to 0.4 of a cent - ya 2c is still might generous
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $133.2K 1.679M

Buyers (Bids)

No. Vol. Price($)
7 575000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 442878 5
View Market Depth
Last trade - 11.43am 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.